HumulinR U-500 (Eli Lilly and Company)


Welcome to the PulseAid listing for the Humulin drug offered from Eli Lilly and Company. This Insulin [Chemical/Ingredient],Insulin [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Eli Lilly and Company
NON-PROPRIETARY NAME: Insulin human
SUBSTANCE NAME: INSULIN HUMAN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Insulin [Chemical/Ingredient],Insulin [EPC]
ROUTE: SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1994-03-31
END MARKETING DATE: 0000-00-00


Humulin R U-500 HUMAN PRESCRIPTION DRUG Details:

Item DescriptionHumulin R U-500 from Eli Lilly and Company
LABELER NAME: Eli Lilly and Company
DEA SCHEDULE:
ACTIVE STRENGTH: 500([iU]/mL)
START MARKETING DATE: 1994-03-31
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0002-8501_78d3163c-1688-4a57-9d91-61b0a5f1a7f4
PRODUCT NDC: 0002-8501
APPLICATION NUMBER: NDA018780

Other INSULIN HUMAN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
A-S Medication SolutionsHumulin
Eli Lilly and CompanyHumulin
Mannkind CorporationAfrezza
Novo NordiskNovolin
Physicians Total Care, Inc.Humalog 70/30
Sanofi-Aventis U.S. LLCAfrezza
TYA PharmaceuticalsNovolin